# An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.

> **NCT01839552** · PHASE4 · WITHDRAWN · sponsor: **University of Louisville**

## Conditions studied

- Pain

## Interventions

- **DRUG:** Fentanyl Citrate Nasal Spray (FCNS)

## Key facts

- **NCT ID:** NCT01839552
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-10
- **Primary completion:** 2017-04
- **Final completion:** 2018-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Site chose to close due to lack of enrollment
- **Last updated:** 2018-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01839552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01839552, "An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01839552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*